A great article about Nuritas’ innovative approach to finding peptide therapeutics for COVID-19 was featured on BioSpace. Thank you to Chelsea Weidman Burke for speaking with our CEO and Founder, Dr Nora Khaldi.
It’s great to see peptides getting attention as credible therapeutic options:
“They are the “Goldilocks” of molecules because of their size – not too small (like small molecules) and not too big (like biologics such as antibodies). They are big enough to bind cellular targets with a large binding pocket but small enough to enter into the cell, giving them access to many more targets inside the cell.”
You can read the full article here.